Microglia and bradykinin cross talk in poststroke cognitive impairment in diabetes

Am J Physiol Cell Physiol. 2021 Apr 1;320(4):C613-C618. doi: 10.1152/ajpcell.00402.2020. Epub 2021 Jan 27.

Abstract

Stroke is one of the leading causes of mortality and the leading cause of long-term disability worldwide. Although cognitive impairment is a common consequence of stroke, the underlying pathophysiological processes that lead to it are still poorly understood. Recently, more studies have shown evidence of the involvement of diabetes in producing a chronic neuroinflammatory state, which ultimately alters the recovery of function and cognition after stroke. To better understand the impact of diabetes on poststroke recovery, here we highlight the recent insights on the role of diabetes in neuroinflammation, especially regarding its effect on microglial function, and the emerging data on the involvement of kinins in both diabetes and neuroinflammation.

Keywords: bradykinin; diabetes mellitus; microglia; poststroke cognitive impairment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bradykinin / metabolism*
  • Brain / metabolism*
  • Brain / pathology
  • Brain / physiopathology
  • Cognition*
  • Cognitive Dysfunction / etiology*
  • Cognitive Dysfunction / metabolism
  • Cognitive Dysfunction / pathology
  • Cognitive Dysfunction / psychology
  • Diabetes Complications / etiology*
  • Diabetes Complications / metabolism
  • Diabetes Complications / pathology
  • Diabetes Complications / psychology
  • Humans
  • Microglia / metabolism*
  • Microglia / pathology
  • Receptors, Bradykinin / metabolism
  • Signal Transduction

Substances

  • Receptors, Bradykinin
  • Bradykinin